Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans

European Journal of Endocrinology

Volumn 150, Issue 2, 2004, Pages 195-200

  Pontiroli, Antonio E ^a   Pizzocri, Pierluigi ^a   Koprivec, Diana ^a   Vedani, Paola ^b   Marchi, Monica ^b   Arcelloni, Cinzia ^b   Paroni, Rita ^b   Esposito, Katherine ^c   Giugliano, Dario ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; GLUCOSE; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIET; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGRESSION ANALYSIS; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; E-SELECTIN; ENDOTHELIN-1; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OBESITY, MORBID; REFERENCE VALUES; REGRESSION ANALYSIS; WEIGHT LOSS;

EID: 1542270314     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500195     Document Type: Article

References (25)

1. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH & Vanhoutte PM. Endothelial dysfunction in diabetes. British Journal of Pharmacology 2000 130 963-974.
2. Steiner M, Reinhardt KM, Krammer B, Ernst B & Blann AD. Increased levels of soluble adhesion molecules in type 2 diabetes mellitus are independent of glycaemic control. Thrombosis and Haemostasis 1994 72 979-984.
3. Bonetti PO, Lerman LO & Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arteriosclerosis, Thrombosis and Vascular Biology 2003 23 168-175.
4. Hattori Y, Kasai K, Nakamura T, Emoto T & Shimoda S. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic cells. Metabolism 1991 40 165-170.
5. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. Journal of Clinical Endocrinology and Metabolism 1995 80 829-835.
6. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. International Journal of Obesity and Related Metabolic Disorders 1999 23 936-942.
7. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G & Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. Journal of Clinical Investigation 1996 97 2601-2610.
8. Piatti PM, Monti LD, Conti M, Baruffaldi L, Galli L, Pontiroli AE et al. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 1996 45 316-321.
9. Yudkin JS, Panahloo A, Stehouwer C, Emeis JJ, Bulmer K, Mohamed-Ali V et al. The influence of improved glycaemic control with insulin and sulphonylureas in acute phase and endothelial markers in type II diabetic subjects. Diabetologia 2000 43 1099-1106.
10. Bagg W, Ferri C, Desideri G, Gamble G, Ockelford P & Rraatvedt GD. The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2001 86 5491-5497.
11. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. Journal of Clinical Endocrinology and Metabolism 2002 87 3555-3561.
12. Anonymous. Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. WHO Technical Report Series 1995 854 1-452.
13. National Institutes of Health, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obesity Research 1998 6 (Suppl 2) 51S-209S.
14. Pontiroli AE, Pizzocri P, Giacomelli M, Marchi M, Vedani P, Cucchi E et al. Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements. Obesity Surgery 2002 12 648-651.
15. Alberti KGMM & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus - provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553.
16. The DCCT Research Group, Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clinical Chemistry 1987 33 2267-2271.
17. Kanai H, Hirakata H, Nakayama M, Nagashima A & Fujishima M. Minimal daily variations of plasma and urinary endothelin-1 in healthy subjects. Clinical Nephrology 1996 46 353-354.
18. Blann AD & Lip GY. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diabetic Medicine 1998 15 634-642.
19. Rothlein R, Mainolfi EA, Czajkowski M & Martin SD. A form of circulating ICAM-1 in human serum. Journal of Immunology 1991 147 3788-3793.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
21. Hotamisligil GS & Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994 43 1271-1278.
22. Schmidt A, Goepfert C, Feitsma K & Buddecke E. Lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF-alpha activated human vascular endothelial cells. Atherosclerosis 2002 164 57-64.
23. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M et al. Reduction of inflammatory cytokine concentrations and of endothelial function in obese women after weight loss over one year. Circulation 2002 105 804-809.
24. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A et al. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 1999 34 568-573.
25. Chen NG, Holmes M & Reaven GM. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. Journal of Clinical Endocrinology and Metabolism 1999 84 3485-3489.